Justin W. Yorke, Director at Processa Pharmaceuticals, Inc. (PCSA), sold 9,700 shares at $4.84 ($46K) on 2021-12-03, disclosed to the SEC on 2021-12-07.
Open-market sale of $46k PCSA by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.84 | 5,500 | $27K | 57.4% |
| 2 | $4.71 | 4,200 | $20K | 42.6% |
| Total | $4.78 avg | 9,700 | $46K | 100% |
| Filing → |
| PCSA | SELL | 2022-01-31 | $6K | — | Filing → |
| PCSA | SELL | 2021-04-15 | $220K | — | Filing → |